|
1
|
Lemjabbar-Alaoui H, Hassan OU, Yang YW and
Buchanan P: Lung cancer: Biology and treatment options. Biochim
Biophyc Acta. 1856:189–210. 2015.
|
|
2
|
Aggarwal A, Lewison G, Idir S, Peters M,
Aldige C, Boerckel W, Boyle P, Trimble EL, Roe P, Sethi T, et al:
The state of lung cancer research: A global analysis. J Thorac
Oncol. 11:1040–1050. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
McIntyre A and Ganti AK: Lung cancer-A
global perspective. J Surg Oncol. 115:550–554. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Zappa C and Mousa SA: Non-small cell lung
cancer: Current treatment and future advances. Transl Lung Cancer
Res. 5:288–300. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Alberg AJ, Wallace K, Silvestri GA and
Brock MV: Invited commentary: The etiology of lung cancer in men
compared with women. Am J Epidemiol. 177:613–616. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Fu JB, Kau TY, Severson RK and Kalemkerian
GP: Lung cancer in women: Analysis of the national surveillance,
epidemiology and end results database. Chest. 127:768–777. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Cerfolio RJ, Bryant AS, Scott E, Sharma M,
Robert F, Spencer SA and Garver RI: Women with pathologic stage I
II, and III non-small cell lung cancer have better survival than
men. Chest. 130:1796–1802. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Schiller JH, Harrington D, Belani CP,
Langer C, Sandler A, Krook J, Zhu J and Johnson DH; Eastern
Cooperative Oncology Group, : Comparison of four chemotherapy
regimens for advanced non-small-cell lung cancer. N Engl J Med.
346:92–98. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Boffetta P, Couto E, Wichmann J, Ferrari
P, Trichopoulos D, Bueno-de-Mesquita HB, van Duijnhoven FJ, Büchner
FL, Key T, Boeing H, et al: Fruit and vegetable intake and overall
cancer risk in the European Prospective Investigation into Cancer
and Nutrition (EPIC). J Natl Cancer Inst. 102:529–537. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Miller AB, Altenhurg HP, Bueno-de-Mesquita
B, Boshuizen HC, Agudo A, Berrino F, Gram IT, Janson L, Linseisen
J, Overvad K, et al: Fruits and vegetables and lung cancer:
Findings from the European Prospective Investigation into Cancer
and Nutrition. Int J Cancer. 108:269–276. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Linseisen J, Rohrmann S, Miller AB,
Bueno-de-Mesquita HB, Büchner FL, Vineis P, Agudo A, Gram IT,
Janson L, Krogh V, et al: Fruit and vegetable consumption and lung
cancer risk: Updated information from the European Prospective
Investigation into Cancer and Nutrition (EPIC). Int J Cancer.
121:1103–1114. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Büchner FL, Bueno-de-Mesquita HB, Ros MM,
Overvad K, Dahm CC, Hansen L, Tjønneland A, Clavel-Chapelon F,
Boutron-Ruault MC, Touillaud M, et al: Variety in fruit and
vegetable consumption and the risk of lung cancer in the European
prospective investigation into cancer and nutrition. Cancer
Epidemiol Biomarkers Prev. 19:2278–2286. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Wang M, Qin S, Zhang T, Song X and Zhang
S: The effect of fruit and vegetable intake on the development of
lung cancer: A meta-analysis of 32 publications and 20,414 cases.
Eur J Clin Nutr. 69:1184–1192. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Zhou Y, Zheng J, Li Y, Xu DP, Li S, Chen
YM and Li HB: Natural polyphenols for prevention and treatment of
cancer. Nutrients. 8:pii: E5152016. View Article : Google Scholar
|
|
15
|
Amararathna M, Johnston MR and Rupasinghe
HP: Plant polyphenols as chemopreventive agents for lung cancer.
Int J Mol Sci. 17:pii: E13522016. View Article : Google Scholar
|
|
16
|
Patil BS, Jayaprakasha GK, Chidambara
Murthy KN and Vikram A: Bioactive compounds: Historical
perspectives, opportunities, and challenges. J Agric Food Chem.
57:8142–8160. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Sak K: Cytotoxicity of dietary flavonoids
on different human cancer types. Pharmacogn Rev. 8:122–146. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Cassidy A and Minihane AM: The role of
metabolism (and the microbiome) in defining the clinical efficacy
of dietary flavonoids. Am J Clin Nutr. 105:10–22. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Chen Z, Zheng S, Li L and Jiang H:
Metabolism of flavonoids in human: A comprehensive review. Curr
Drug Metab. 15:48–61. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Sak K: The Val158Met polymorphism in COMT
gene and cancer risk: Role of endogenous and exogenous catechols.
Drug Metab Rev. 49:56–83. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Cao Y, Chen ZJ, Jiang HD and Chen JZ:
Computational studies of the regioselectivities of COMT-catalyzed
meta-/para-O methylations of luteolin and quercetin. J Phys Chem B.
118:470–481. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Lieber M, Smith B, Szakal A, Nelson-Rees W
and Todaro G: A continuous tumor-cell line from a human lung
carcinoma with properties of type II alveolar epithelial cells. Int
J Cancer. 17:62–70. 1976. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Gazdar AF, Girard L, Lockwood WW, Lam WL
and Minna JD: Lung cancer cell lines as tools for biomedical
discovery and research. J Natl Cancer Inst. 102:1310–1321. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Mosmann T: Rapid colorimetric assay for
cellular growth and survival: Application to proliferation and
cytotoxicity assays. J Immunol Methods. 65:55–63. 1983. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Kupcsik L: Estimation of cell number based
on metabolic activity: The MTT reduction assay. Methods Mol Biol.
740:13–19. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Loizzo MR, Said A, Tundis R, Hawas UW,
Rashed K and Menichini F, Frega NG and Menichini F: Antioxidant and
antiproliferative activity of Diospyros lotus L. extract and
isolated compounds. Plant Foods Hum Nutr. 64:264–270. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Tan J, Wang B and Zhu L: DNA binding,
cytotoxicity, apoptotic inducing activity, and molecular modeling
study of quercetin zinc(II) complex. Bioorg Med Chem. 17:614–620.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Tan J, Wang B and Zhu L: DNA binding and
oxidative DNA damage induced by a quercetin copper(II) complex:
Potential mechanism of its antitumor properties. J Biol Inorg Chem.
14:727–739. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Tan J, Zhu L and Wang B: From GC-rich DNA
binding to the repression of survivin gene for quercetin nickel(II)
complex: Implications for cancer therapy. Biometals. 23:1075–1084.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Robaszkiewicz A, Balcerczyk A and Bartosz
G: Antioxidative and prooxidative effects of quercetin on A549
cells. Cell Biol Int. 31:1245–1250. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Chan ST, Yang NC, Huang CS, Liao JW and
Yeh SL: Quercetin enhances the antitumor activity of trichostatin A
through upregulation of p53 protein expression in vitro and in
vivo. PLoS One. 8:e542552013. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Katalinic M, Rusak G, Domaćinović Barović
J, Sinko G, Jelić D, Antolović R and Kovarik Z: Structural aspects
of flavonoids as inhibitors of human butyrylcholinesterase. Eur J
Med Chem. 45:186–192. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Kawaii S, Tomono Y, Katase E, Ogawa K and
Yano M: Antiproliferative activity of flavonoids on several cancer
cell lines. Biosci Biotechnol Biochem. 63:896–899. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Kim DH, Jung EA, Sohng IS, Han JA, Kim TH
and Han MJ: Intestinal bacterial metabolism of flavonoids and its
relation to some biological activities. Arch Pharm Res. 21:17–23.
1998. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Hernandez J, Goycoolea FM, Quintero J,
Acosta A, Castañeda M, Dominguez Z, Robles R, Vazquez-Moreno L,
Velazquez EF, Astiazaran H, et al: Sonoran propolis: Chemical
composition and antiproliferative activity on cancer cell lines.
Planta Med. 73:1469–1474. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Said A, Tundis R, Hawas UW, El-Kousy SM,
Rashed K, Menichini F, Bonesi M, Huefner A, Loizzo MR and
Menichinib F: In vitro antioxidant and antiproliferative activities
of flavonoids from Ailanthus excelsa (Roxb.) (Simaroubaceae)
leaves. Z Naturforsch C. 65:180–186. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Han BJ, Li W, Jiang GB, Lai SH, Zhang C,
Zeng CC and Liu YJ: Effects of daidzein in regards to cytotoxicity
in vitro, apoptosis, reactive oxygen species level, cell cycle
arrest and the expression of caspase and Bcl-2 family proteins.
Oncol Rep. 34:1115–1120. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Yang Y, Zang A, Jia Y, Shang Y, Zhang Z,
Ge K, Zhang J, Fan W and Wang B: Genistein inhibits A549 human lung
cancer cell proliferation via miR-27a and MET signaling. Oncol
Lett. 12:2189–2193. 2016.PubMed/NCBI
|
|
39
|
Kano M, Takayanagi T, Harada K, Sawada S
and Ishikawa F: Bioavailability of isoflavones after ingestion of
soy beverages in healthy adults. J Nutr. 136:2291–2296.
2006.PubMed/NCBI
|
|
40
|
Manach C, Williamson G, Morand C, Scalbert
A and Rémésy C: Bioavailability and bioefficacy of polyphenols in
humans. I. Review of 97 bioavailability studies. Am J Clin Nutr.
81(1Suppl): 230S–242S. 2005.PubMed/NCBI
|
|
41
|
Lee J and Mitchell AE: Pharmacokinetics of
quercetin absorption from apples and onions in healthy humans. J
Agric Food Chem. 60:3874–3881. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Sak K and Everaus H: Sulfotransferase 1A1
as a biomarker for susceptibility to carcinogenesis: From molecular
genetics to the role of dietary flavonoids. Curr Drug Metab.
17:528–541. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Ruan Y, Hu K and Chen H: Autophagy
inhibition enhances isorhamnetin-induced mitochondria-dependent
apoptosis in non-small cell lung cancer cells. Mol Med Rep.
12:5796–5806. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Zhang BY, Wang YM, Gong G, Zhao H, Lv XY,
Yuan GH and Han SR: Isorhamnetin flavonoid synergistically enhances
the anticancer activity and apoptosis induction by cisplatin and
carboplatin in non-small cell lung carcinoma (NSCLC). Int J Clin
Exp Pathol. 8:25–37. 2015.PubMed/NCBI
|
|
45
|
Li Q, Ren FQ, Yang CL, Zhou LM, Liu YY,
Xiao J, Zhu L and Wang ZG: Anti-proliferation effects of
isorhamnetin on lung cancer cells in vitro and in vivo. Asian Pac J
Cancer Prev. 16:3035–3042. 2015. View Article : Google Scholar : PubMed/NCBI
|
